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Impact of copper and iron binding properties on the anticancer 
activity of 8-hydroxyquinoline derived Mannich bases  
Veronika F.S. Papea,†, Nóra V. Mayb, G. Tamás Gálb, István 
Szatmáric, Flóra Szeria,§, Ferenc Fülöpc, Gergely Szakácsa,d,*, 
Éva A. Enyedye,* 
The anticancer activity of 8-hydroxyquinolines relies on complex formation with redox active copper and iron ions. Here 
we employ UV-visible spectrophotometry and EPR spectroscopy to compare proton dissociation and complex formation 
processes of the reference compound 8-hydroxyquinoline (Q-1) and three related Mannich bases to reveal possible 
correlations with biological activity. The studied derivatives harbor a CH2-N moiety at position 7 linked to morpholine (Q-
2), piperidine (Q-3), and chlorine and fluorobenzylamino (Q-4) substituents. Solid phase structures of Q-3, Q-4·HCl·H2O, 
[(Cu(HQ-2)2)2]·(CH3OH)2·Cl4·(H2O)2, [Cu(Q-3)2]·Cl2 and [Cu(HQ-4)2(CH3OH)]·ZnCl4·CH3OH were characterized by single-crystal 
X-ray diffraction analysis. In addition, the redox properties of the copper and iron complexes were studied by cyclic 
voltammetry, and the direct reaction with physiologically relevant reductants (gluthathione and ascorbic acid) was 
monitored. In vitro cytotoxicity studies conducted with the human uterine sarcoma MES-SA/Dx5 cell line reveal the 
significant cytotoxicity of Q-2, Q-3, Q-4 in the low micromolar range (IC50 values 0.2-3.3 M). Correlation analysis of the 
anticancer activity and the metal binding properties of the compound series indicates that, at physiological pH, weaker 
copper(II) and iron(III) binding results in elevated toxicity (e.g. Q4: pCu=13.0, pFe=6.8, IC50=0.2 M vs. Q1: pCu=15.1, 
pFe=13.0 IC50=2.5 M). Whereas the studied 8-hydroxyquinolines preferentially bind coper(II) over iron(III), the cyclic 
voltammetric data revealed that the more cytotoxic ligands preferentially stabilize the lower oxidation state of the metal 
ions. A linear relationship between the pKa (OH) and IC50 values of the studied 8-hydroxyquinolines was found. In summary, 
we identify Q-4 as a potent and selective anticancer candidate with significant toxicity in drug resistant cells.  
 
Introduction 
The broad pharmacological activity of 8-hydroxyquinoline (Q-1, 
Chart 1) and its derivatives has been exploited in several medicinal 
applications ranging from antineurodegenerative, anti-
inflammatory, anticancer and antimicrobial therapies.
1,2
 In all of 
these applications, the therapeutic effect of 8-hydroxyquinolines is 
believed to rely on metal chelation. Indeed, the (N,O) donor set of 
the planar, heterocyclic scaffold possesses a high affinity for various 
transition metal ions. For example, Clioquinol (5-chloro-7-iodo-8-
hydroxyquinoline, CQ), a lipophilic derivative of Q-1, has been 
explored as a treatment for Alzheimer's disease based on its ability 
to disrupt the interaction between zinc(II) and copper(II) ions and 
the Aβ peptide in the brain.
3,4
 CQ and numerous other 8-
hydroxyquinoline derivatives were reported to exhibit a remarkable 
anticancer effect. The anticancer effect of 8-hydroxyquinolines is 
also related to complexation with endogenous metals, above all the 
redox active copper and iron ions.
5–7
 Despite the continuous 
interest in novel 8-hydroxyquinolines as candidate anticancer 
agents, relatively little is known about their exact mechanism of 
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toxicity. Studies have suggested several alternative models, 
including lysosomal disruption, inhibition of proteasome or the 
histone deacetylase, inhibition of angiogenesis, or the inhibition of 
the ribonucleotide reductase.
8–10
 Labile iron and copper pools in the 
cytoplasm represent only rather low concentrations under healthy 
conditions, as most of these metal ions are bound to proteins.
11,12
  
However, the concentration of labile metal ions may be significantly 
increased in cancer cells.
13
 CQ can also act as an ionophore, 
inducing the transfer of metal ions across biological membranes, 
either in or out of cells.
10
 The antitumor activity of 8-
hydroxyquinolines may also be linked to the toxicity of their metal 
complexes, as shown for copper(II),
6,14
 ternary ruthenium(II),
15
 half-
sandwich organoruthenium,
16–19
 organorhodium,
16
 platinum(II)
20
 
and gallium(III) 
21,22
. 
Mannich bases of 8-hydroxyquinolines were reported to possess 
high potency against human cancer cells,
23,24
 and our meta-analysis 
of the cytotoxicity of various 8-hydroxyquinolines revealed the 
importance of the CH2-N subunit at position 7 for cytotoxicity.
25,26,27
 
In this study we have chosen three 8-hydroxyquinoline derivatives 
in which the crucial CH2-N building block is retained. Morpholine (7-
(morpholinomethyl)quinolin-8-ol, Q-2) and piperidine (7-(piperidin-
1-ylmethyl)quinolin-8-ol, Q-3) moieties are introduced at position 7 
(Chart 1) to decrease the hydrophobic character of the reference 
compound Q-1. To further optimize the hydrophilic-lipophilic 
character of the compounds, Q-4 was developed, bearing a chlorine 
at position 5 and a fluorobenzylamino substituent at position 7 (5-
chloro-7-((2-fluorobenzylamino)methyl)quinolin-8-ol, Q-4, Chart 1).  
In this work we characterize the effect of these derivatizations on 
the cytotoxicity, proton dissociation processes, lipophilicity, 
copper(II) and iron(III) binding abilities and also study the redox 
properties of the relevant metal complexes to establish the 
relationship between the determined thermodynamic parameters 
and the biological activity of the compounds. Correlation analysis 
exploring the relationship between physico-chemical and biological 
properties provides an opportunity to better understand the 
mechanism of action of these compounds. Based on quantitative 
relationship analyses between chemical structures and bioactivity, 
between a set of thermodynamic parameters and toxicity, more 
reliable structure activity predictions can be made. Elegant 
examples for this type of correlation studies were shown for e.g. 
polyoxometalates regarding their antibacterial activity,
28
 or for the 
antitumor and antiangiogenic effect of half-sandwich Ru(
6
-p-
cymene) and Ir(
5
-C5Me5) benzimidazole complexes.
29
  
Results and discussion 
Synthesis and characterization of the 8-hydroxyquinoline derived 
Mannich bases 
Q-1 is a commercially available compound, while Q-2, Q-3 were 
obtained from the National Cancer Institute’s Developmental 
Therapeutics Program (Chart 1).
27
 As displayed in Scheme 1, Q-4 
was synthesized by coupling 5-chloro-8-hydroxyquinoline with 2-
fluorobenzylamine in the presence of paraformaldehyde via a 
modified Mannich reaction under microwave conditions. The 
formed [1,3]oxazino[5,6-h]quinolone derivative was isolated by 
crystallization from an n-hexane:ethyl acetate mixture and 
converted to the desired product as Q-4·HCl in ethanolic hydrogen  
 
Chart 1. Structures of the reference compound 8-hydroxyquinoline (Q-1) 
and its derivatives (Q-2, Q-3, Q-4) reported in this work in their neutral 
form. 
 
chloride in excellent yield. NMR spectra were in agreement with the 
expected structures, enabling the assignment of all 
1
H and 
13
C 
resonances. The purity of Q-4·HCl was further confirmed by 
elemental analyses. 
The structures of Q-3 and Q-4·HCl·H2O were established by single 
crystal X-ray diffraction (Figure 1). Crystal data and structure 
refinement parameters of the crystals are given in Table S1; 
selected bond distances and angles are listed in Tables S2, S4. Q-3 
crystallized in its neutral form in the orthorhombic crystal system, in 
space group P212121, without solvent inclusion. 
The molecular structure is stabilized by the O1-H1O…N10 
intramolecular hydrogen bond. The crystal structure is stabilized by 
weak C-H…O and C-H… interactions with the participation of the 
piperidine protons (Figure S1 and Tables S2, S3). Q-4 crystallized in 
its protonated form with Cl
-
 counter ion and a water molecule in 
the triclinic crystal system, in space group P-1. The conformation is 
stabilized by a weak intermolecular interaction between O1 and 
one of the amino protons. The neighboring molecules are 
connected by O-H…N and C-H…O hydrogen bonds, and … off-
centered parallel stacking) interactions (Figure S2 and Tables S4, 
S5). 
 
 
 
Scheme 1. Two step synthesis of 5-chloro-7-((2-fluorobenzyl-
amino)methyl)quinolin-8-ol Q-4, starting from 5-chloro-8-hydroxyquinoline 
via a modified Mannich reaction in ethanol (EtOH) at 100 °C, under 
microwave (MW) conditions, followed by an acidic cleavage of the dihydro-
[1,3]-oxazine ring with HCl in ethanolic solution. 
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Fig. 1. ORTEP views of Q-3 (a) and Q-4·HCl·H2O (b) at 30% probability level of 
displacement ellipsoids. Blue lines indicate the suggested intramolecular 
hydrogen bonds. Selected bond distances and bond angles are listed in 
Tables S2, S4. 
Table 1 In vitro cytotoxicity (expressed as IC50) of the studied compounds in 
the human uterine sarcoma MES-SA/Dx5 cell line and in primary 
hepatocytes.a 
IC50 / M Q-1 Q-2 Q-3 Q-4 doxo-
rubicin 
MES-
SA/Dx5 
2.46±0.69 3.27±0.39 0.86±0.26 0.20±0.06 2.13±0.65 
primary 
hepatocytes 
115±18 243±69 163±35 40.4±8.9 2.14±1.11 
a Determined by means of the MTT assay after exposure for 72 h. Values are 
means ± standard deviations obtained from at least three independent 
experiments.
 
In vitro toxicity of Q-1 and its Mannich base derivatives against 
cancer cell line and primary hepatocytes 
The in vitro cytotoxic activity of compounds Q-1 to Q-4 was 
determined in the human uterine sarcoma MES-SA/Dx5 cell line and 
in primary hepatocytes (Table 1). The compounds demonstrated 
marked selective cytotoxic activity in a micromolar and 
submicromolar concentration range in the drug resistant human 
uterine sarcoma MES-SA/Dx5 cell line, increasing in the following 
order Q-2 < Q-1 < Q-3 < Q-4. Notably, Q-3 and Q-4 possess even 
stronger cytotoxic activity than the FDA approved anticancer agent 
doxorubicin. To exclude non-specific toxic effects related to the 
multiple targets of metal chelators,
30
 primary hepatocytes were 
also included in the study. Compared to doxorubicin, the newly 
investigated compounds displayed a manifold higher selectivity 
towards cancer cells (Table 1). Due to the high proliferation rate, 
malignant cancer cells show increased reliance on metal ions, which 
are required e.g. as co-factors in enzymes catalyzing essential steps 
in DNA-synthesis, as well as for cell cycle progression and cellular 
growth 
31–34
. For example, the rate limiting step in DNA synthesis is 
the reduction of ribonucleotides, which is catalyzed by the iron 
dependent enzyme ribonucleotide reductase (RR) 
35,36
. Thus, 
selective toxicity of the studied compounds to the human uterine 
sarcoma cells over hepatocytes might be the result of the altered 
metal homeostasis of the cancerous cells.   
 
Proton dissociation processes of the studied 8-hydroxyquinolines 
The proton dissociation constant (Ka) is a key physico-chemical 
parameter influencing the pharmacokinetic properties of the 
compounds. Determination of the pKa value allows the estimation 
of the distribution of the chemical forms of the molecule in the 
various protonation states at a given pH. As the pKa values of the 
reference compound Q-1 and Q-3 are available, although for Q-3 
under different conditions,
16,37
 we determined the pKa values of Q-
2, Q-3 and Q-4 by UV‒visible (UV‒Vis) spectrophotometric titrations 
in an aqueous solution. This method requires lower concentrations 
as compared to pH-potentiometry, which are compatible with the 
limited water-solubility of the compounds. The UV‒Vis spectra of all 
ligands recorded in the pH range 2 to 11.5 show characteristic 
spectral changes upon the deprotonation processes. 
Representative spectra for Q-2, as well as molar absorbance spectra 
of individual ligand species in the differently protonated forms are 
shown in Figure 2. The recorded absorbance spectra were 
deconvoluted resulting in the pKa values of the compounds and the 
molar absorbance spectra of the various species (Table S6). The pKa 
values were assigned to the particular moieties by careful analysis 
of the spectral changes (Scheme 2). The deprotonation processes of 
Q-1 are well-described in the literature, 
16,37
 and pK1 and pK2 values 
correspond to the deprotonation of the quinolinium-NH
+
 and the 
phenolic-OH moieties, respectively, as indicated in Scheme 2. 
Values obtained for Q-3 are in good agreement with those reported 
in the presence of KNO3 instead of KCl.
16
 
 
 
 
Fig. 2. UV‒Vis absorption spectra of Q-2 (a) recorded at different pH values 
in aqueous solution and the calculated molar absorption spectra of the 
individual ligand species (b). (cQ-2 = 50 µM; T = 25.0 °C; I = 0.20 M KCl; l = 
2 cm) 
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The most pronounced spectral changes are linked to the 
deprotonation of the hydroxyl functional group. The emerging 
strong bands with higher λmax values originate from the more 
extended conjugated -electron system in the deprotonated 
form.
16,37
 In comparison to the 8-hydroxyquinoline scaffold 
(Scheme 2), the morpholino-substituent in 7-position in Q-2 
increases the pKa value of the phenolic-OH by almost one order of 
magnitude, possibly due to the formation of a hydrogen bond 
between the OH and the morpholine-N in the HL form of the ligand, 
which hinders deprotonation. In contrast, the protonated (thus 
positively charged) amine moiety of the piperidine of Q-3 and of the 
benzylamine in case of Q-4 decrease the proton dissociation 
constants of the OH group by 2.5 and 4.4 orders of magnitude, 
respectively, as compared to Q-1. These results are consistent with 
the lower pKa values reported for numerous hydroxamic and 
carboxylic acids due to the electron withdrawing effect of the 
protonated piperidinium moiety.
38
 As confirmed by single crystal X-
ray diffraction analysis of the solid compounds Q-3 and Q-4∙HCl·H2O 
(vide supra), possible hydrogen bond formations between the 
phenolate and the piperidinium moiety of Q-3 (in the zwitterionic L 
form) can additionally contribute to the diminished pKa values due 
to the stabilization of the conjugate base. Intramolecular hydrogen 
bonding is also probable in the HL form of Q-4 between the 
phenolate and the protonated benzylamine moieties. The pKa of the 
OH group in Q-4 (pK1) is also affected by the electron withdrawing 
effects of the chloro-substituent. 
pKa values assigned to the deprotonation of the quinolinium-NH
+
 
moiety of the R7-substituted ligands (pK1 for Q-2 and Q-3) were 
found to be considerably lower compared to that of Q-1 as a 
consequence of the electron withdrawing effect of the protonated 
methylene-amine groups in the Mannich bases. In Q-4 the 
deprotonation of this moiety could not be observed under the 
applied experimental conditions, since it most probably takes place 
at lower pH (< 2) due to the additional negative inductive effect of 
the halogen atom (the predicted pKa value for the quinolinium-NH
+
 
moiety in Q-4 is 0.98).
39
 
Based on smaller spectral alterations further pKa values could be 
assigned corresponding to the deprotonation processes of the non-
coordinating nitrogens, such as the morpholinium-NH
+
 of Q-2 and 
the benzylamino-NH
+
 of Q-4. Deprotonation of the piperidinium-
NH
+
 of Q-3 most probably takes place only at strongly basic pH (pKa 
> 11.5). 
On the basis of the obtained pKa values, species distribution was 
calculated at pH 7.4 (Scheme 2). Thus, the neutral forms of these 
compounds predominate at physiological pH; however Q-3 and Q-4 
are mostly present in their zwitterionic L and HL forms, respectively. 
The lipophilicity of the compounds was characterized by the n-
octanol/water distribution coefficients at pH 7.4 (logD7.4 values in 
Scheme 2). These data revealed that while introduction of the 
aliphatic methylene amines in position R7 of Q-2 and Q-3 increases 
the hydrophilic character of the ligands in comparison to the 
unsubstituted scaffold Q-1, the additional benzyl moiety on the 
methylene amine in R7 and the halogen substituent in R5 
significantly increase the lipophilicity of Q-4. 
 
 
 
 
 
Scheme 2. Proton dissociation steps of the studied 8-hydroxyquinolines and their pKa values. Predominant species and n-octanol/water distribution 
coefficients (logD7.4) determined at pH 7.4. (T = 25 C, I = 0.20 M (KCl)) 
a Data taken from reference.43 
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Table 2. Logarithm of the overall stability constants (log) of the copper(II) 
and iron(III) complexes of ligands Q-2 to Q-4 determined by UV–vis 
spectrophotometric titrations and pM values calculated at pH 7.4. Data for 
Q-1 are also shown for comparison. (Charges of the complexes are omitted 
for clarity. L is neutral for Q-3 and singly negatively charged for Q-1, Q-2 and 
Q-4.) (T = 25 C, I = 0.20 M (KCl)) 
 Q-1 Q-2 Q-3 Q-4 
log [FeLH] – 19.80±0.04 – 18.46±0.04 
log [FeL] 13.69
a 16.90±0.04 11.11±0.02 14.31 ±0.05 
log [FeL2H2] – – – 34.44±0.04 
log [FeL2H] – 35.18±0.04 – 28.50±0.06 
log [FeL2] 26.3
a – 20.32±0.03 – 
log [FeL3H] – 49.03±0.03 – – 
log [FeL3] 36.9
a 42.49±0.03 25.42±0.07 – 
pM c 21.1 21.1 16.0 14.8 
pM* d 13.0 13.0 8.0 6.8 
log [CuLH] – – – 16.87±0.03 
log [CuL] 12.1
b 16.54±0.04 10.6 ±0.1 10.96±0.07 
log [CuL2H2] – – – 32.54±0.06 
log [CuL2H] – 34.67±0.04 – 26.94±0.06 
log [CuL2] 23.0
b 27.5 ±0.1 19.4±0.1 – 
pM c 15.1 17.4 14.9 13.0 
a Data taken from Ref. 41 b Data taken from Ref. 42 c pM = ‒log[M] calculated 
at pH = 7.4, cM= 1 M; cL= 10 M.
 d pM* = ‒log([Fe] + i×[Fei(OH)j]) calculated 
at pH = 7.4, cM= 1 M; cL= 10 M. 
 
 Complex formation of the studied 8-hydroxyquinolines with 
iron(III) and copper(II) in solution 
The anticancer activity of 8-hydroxyquinolines may be related to 
the formation of (redox active) metal complexes with essential ions 
such as iron and copper
7,40
 Therefore, we investigated complex 
formation of Q-2 to Q-4 with two physiologically relevant metal ions 
(iron(III) and copper(II)), in order to reveal a possible relationship 
between the metal binding ability of these ligands and their 
cytotoxicity. Results were compared to data reported for Q-1.
41,42
 
The complexation of the 8-hydroxyquinoline derived Mannich bases 
with iron(III) and copper(II) was studied by UV‒Vis 
spectrophotometry. During titrations with both metal ions the 
absorbance values tend to decrease at pH > ~8. In case of iron(III), 
hydrolysis of the metal ion may suppress complex formation at 
alkaline pH values, whereas neutral copper(II) complexes precipitate at 
pH > ~9 (Figure S3 for Q-2, Q-4 complexes). Given these possible 
artefacts, evaluation was restricted to data collected at pH < 8. 
Spectral changes upon complexation with iron(III) detected in the 
350-750 nm wavelength range were the most useful for the 
calculations of overall stability constants, since bands located in this 
range are relatively well-separated from the ligand bands (see 
representative spectra for Q-3 in Figure 3). 
The stochiometries of the metal complexes and the overall stability 
constants () furnishing the best fits to the experimental data are 
shown in Table 2. 
The molar absorbance spectra of the individual metal complexes 
were also computed (see max and molar absorptivity values in 
Table S7). As expected, mono and bis complexes are formed with 
both metal ions, while tris complexes could also be detected with 
iron(III). In the case of Q-2 and Q-4, further protonated complexes 
were formed, in which the protons were attributed to the non-
coordinating protonated morpholinium and secondary amine 
moieties, respectively (Table 2). 
Based on the overall stability constants (Table 2), concentration 
distribution diagrams were computed at various metal-to-ligand 
ratios (exemplarily diagrams are shown for 5 µM ligand 
concentration at pH 7.4 in Figure S4). These data reveal the 
different speciation of the four ligands at physiological pH. 
Complexation of iron(III) with Q-1 and Q-2 results in predominantly 
tris-ligand complexes, while for Q-3, the formation of the bis-
complex is more pronounced. In the iron(III) − Q-4 system, mono 
and protonated bis complexes co-exist at pH 7.4. Notably, the 
formation of tris complexes is not observed even at 1:3 metal-to-
ligand ratio, most probably due to sterical reasons. In case of 
copper(II) complexation, at a 1:2 metal-to-ligand ratio the 
coordination sphere of the metal ion is likely to be saturated in the 
physiologically relevant pH range, as almost only bis complexes are 
formed exclusively under this condition. 
The overall stability constants of the complexes cannot be 
compared directly owing to the different basicities of the ligands 
and number of dissociable protons. However, the stability constants 
for the iron(III) species are generally higher than those of the 
corresponding copper(II) complexes, the significantly different 
extent of hydrolysis of these metal ions should be also taken into 
consideration when the solution stabilities are compared. 
Therefore, in order to compare the metal binding ability of the four 
investigated 8-hydroxyquinolines adequately, pM values (negative 
decadic logarithm of the equilibrium concentration of unbound 
metal ion) were computed at pH 7.4 (Table 2). In the case of 
iron(III), the formation of hydroxido species was also taken into 
account (pM* values in Table 2). At pH 7.4, the iron binding capacity 
of the investigated ligands follows the order Q-1 ~ Q-2 > Q-3 > Q-4, 
and a similar trend (Q-2 > Q-1 > Q-3 > Q-4) was obtained for the 
copper(II) complexes. A comparison of the pM (of copper(II)) and 
pM* (of iron(III)) values indicates that at pH 7.4, the studied ligands 
preferentially bind copper(II) over iron(III). 
To further investigate the coordination modes of the copper(II) 
complexes in solution, electron paramagnetic resonance (EPR) 
spectroscopic measurements were performed. 
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Fig. 3. UV-Vis absorption spectra recorded for the iron(III) − Q-3 (1:3) system at different pH values (a) and calculated UV-Vis molar absorption spectra of the 
various complexes (b). (cQ-3 = 50 M; T = 25.0 ˚C; I = 0.20 M KCl; l = 2 cm).
 
 
EPR spectra were measured at room temperature for samples 
containing copper(II) and the investigated ligands (deprotonated 
with one equivalent of NaOH) in equimolar concentrations and at 
two-fold ligand excess (Figure 4). Dimethyl sulfoxide (DMSO) was 
used as solvent in which the complexes are soluble in the mM 
concentration range. The measured spectra could be deconvoluted 
into the individual spectra of mono- and bis complexes (and free 
copper(II)). Notably, the [CuL2] and [CuL2H] complexes could not be 
distinguished, as side chain deprotonations have a negligible impact 
on the EPR spectra. The EPR data indicate that formation of the 
mono complexes seems to be more pronounced in DMSO than in 
the aqueous solution. Additionally, the fraction of the bis complex is 
much lower for Q-4 as compared to the other ligands, most 
probably due to sterical reasons. The isotropic EPR parameters 
obtained by the simulation of room temperature spectra are shown 
in Table 3.  
 
 
Fig. 4. Experimental (black) and simulated (grey) room temperature EPR 
spectra recorded for the copper(II) – ligand systems (Q-1 - Q-4) in DMSO at 
cCu(II) = 2 mM in the presence of one (a) or two (b) equivalents of the ligand. 
Concentration ratios of the mono and bis complexes obtained from the 
simulation are indicated in the spectra. 
The go values of the copper(II) complexes support a similar 
bidentate (N,O
−
) 8-quinolinolato coordination mode in all 
complexes. It is worth noting that the go constant of the mono
 
 
complex of Q-4 is higher compared to those of the complexes of the 
other 3 ligands, indicating a somewhat weaker ligand field. 
EPR spectra were also recorded at 77 K in methanol and in toluene. 
Interestingly, these EPR spectra revealed that while for Q-1 and Q-3 
the bis complexes form monomers, for Q-2 and Q-4, additional 
dimeric species were detectable (Figure S5, Table S8) in the frozen 
samples. A doublet peak detected at around 3000 and 3500 G and 
the half-field signal at 1500 G unambiguously show the appearance 
of a coupled-spin system (S=1), which can be established by two 
neighboring copper(II) centers. From the simulation of the spectra 
the orientation of the copper(II) centers can be calculated (polar 
angles:  = 28.5°,  = −5.0°), showing that one center is above to 
the other. A copper-copper distance of 3.88 Å was calculated from 
the dipolar coupling by using the point-dipole approach. These 
results are in good agreement with the obtained X-ray crystallo-
graphic results (vide infra) where  = 35.1° and  = 0° could be 
measured for Q-2 and  = 30.6° and  = 0° for Q-4, and the copper- 
copper distances are 3.3935(7) Å and 3.8354(8) Å respectively. 
From this result we conclude that the bis complexes of Q-2 and Q-4 
preferably form dimers in frozen solution as well as in solid state. 
Table 3. Isotropic EPR parameters obtained by the simulation of room 
temperature EPR spectra measured in DMSO.a 
Ligand Complex go Ao/G aN/G 
DMSO Cu(DMSO) 2.170 35 - 
Q-1 mono 2.144 59 9 
 bis 2.116 73 11, 11 
Q-2 mono 2.142 57 10 
 bis 2.113 71 11, 11 
Q-3 mono 2.144 59 8 
 bis 2.114 72 11, 11 
Q-4 mono 2.152 68 9 
 bis 2.113 63 11, 11 
a The experimental error is ±0.001 for go, ±1 G for Ao and aN. 
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Fig. 5. The cyclic dimer structure of complex cation [(Cu(HQ-2)2)2]
4+ in [(Cu(HQ-2)2)2]·(CH3OH)2·Cl4·(H2O)2 (a), [(Cu(Q-3)2]
2+ in [Cu(Q-3)2]·Cl2 (b) and [(Cu(HQ-
4)2(CH3OH)]
2+ in [Cu(HQ-4)2(CH3OH)]·ZnCl4·CH3OH at 30% probability level of displacement ellipsoids. Hydrogens, as well as the chloride and [ZnCl4]
2- anions, 
water and methanol molecules present in the crystal lattice are omitted for clarity. Selected bond lengths (Å) and angles (°) for [(Cu(HQ-2)2)2]
4+: Cu1-O1 
1.931(3), Cu1-O11 1.954(3), Cu1-N1 1.989(3), Cu1-N21 1.967(3), Cu1-O11A 2.681(3), O1-Cu1-O11 179.5(1), N1-Cu1-N21 171.0(1), O1-Cu1-N1 84.2(1), O1-
Cu1-N21 95.7(1), O11A-Cu1-N1 92.8(1), O11A-Cu1-N21 96.1(1), O1-Cu1-O11A 92.4(1), O11-Cu1-O11A 87.2(1). Selected bond lengths (Å) and angles (°) for 
[(Cu(Q-3)2]
2+: Cu2-O1 1.945(6), Cu2-N1 1.951(8), O1-Cu2-N1 85.1(3), O1-Cu2-N1 94.9(3), O1-Cu2-O1 180.0, N1-Cu2-N1 180.0. Selected bond lengths (Å) and 
angles (°) for [(Cu(HQ-4)2(CH3OH)]
2+: Cu1-O1 1.969(2), Cu1-O2 1.952(3), Cu1-N1 1.989(4), Cu1-N21 1.978(4), Cu1-O3 2.314(4), O1-Cu1-O2 174.53(13), N1-
Cu1-N21 174.63(15), O1-Cu1-N1 84.26(11), O1-Cu1-N21 97.11(11), O2-Cu1-N1 93.95(13), O2-Cu1-N21 84.22(13), O1-Cu1-O3 87.43(11), O3-Cu1-N1 
97.45(14), O3-Cu1-N21 87.81(14), O1-Cu1-O3 87.43(11). 
 
 
Solid phase characterization of the copper(II) complexes of the 
studied 8-hydroxyquinolines 
Single crystals suitable for X-ray crystallography were obtained from 
methanolic solution in the case of the copper(II) complexes of Q-2, 
Q-3 and Q-4 as [(Cu(HQ-2)2)2]·(CH3OH)2·Cl4·(H2O)2, [Cu(Q-3)2]·Cl2 
and [Cu(HQ-4)2(CH3OH)]·ZnCl4·CH3OH (Figure 5). Crystal data and 
structure refinement parameters are given in Table S1. Selected 
bond distances and angles are specified in the legend of Figure 5, 
while packing arrangements are shown in Figures S6-8. As expected 
based on their structural similarity, the X-ray diffraction studies 
reveal a similar bidentate (N,O
-
) 8-quinolinolato coordination mode 
for copper(II) complexes of Q-3, Q-4 and the reference compound 
Q-1.
44
 Despite a coordination with the same donor atom set, the 
copper(II) complex of Q-2 adopts a cyclic dimer [(Cu(HQ-2)2)2]
4+
 
form, in which the phenolato oxygen acts as a bridging atom 
between two metal centers of the neighboring complexes 
(Figure S6). However, the presence of long intermolecular contacts 
Cu1···O11A or Cu1A···O11 (Å) strongly suggests the weak 
association of complexes into dimers, which most probably 
dissociate in aqueous solution with the formation of monomeric 
species. 
[(Cu(HQ-2)2)2]·(CH3OH)2·Cl4·(H2O)2 crystallized in the monoclinic 
C2/c space group (Figures 5, S6). The ligand in this complex is in the 
neutral zwitter ionic HL form (with phenolate-O
-
 and morpholinium-
NH
+
). The metal ion is coordinated in a square-pyramidal mode, 
with the basal plane defined by atoms O1 and N1 from one Q-2 
ligand and O11 and N21 from another Q-2 ligand in trans position 
to each other, while atom O11 from another bis complex occupies 
the axial position of the metal ion (and vice versa) with a long Cu1-
O11 distance (2.680(3) Å). The complex has an inversion centre 
symmetry, half of the molecule can be found in the asymmetric 
unit. The charge of the complex is neutralized by chloride counter 
ions. It is worth to mention that the O33 atom of a neighbouring 
morpholine ring gets in close distance of 2.810(3) Å to the second 
axial position of the copper atom (Figure S6). The copper-copper 
dinstance is 3.3935(7) Å in the dimeric complex. The complex 
structure is further stabilized by two intramolecular hydrogen 
bonds C22-H22…O1 and C29-H29B…O1, and the main 
intermolecular interactions are listed in Table S9. 
[Cu(Q-3)2]·Cl2 crystallized in the monoclinic crystal system, in space 
group P21/n (Figures 5, S7). The ligand shows a bidentate (N,O
-
) 
coordination mode forming a square planar type geometry around 
the copper center. The planar arrangement of the two quinolinolato 
rings is also secured by intramolecular hydrogen bond of C2-
H2…O1. In addition to a N-H…Cl and three weak C-H…Cl hydrogen 
bonds, … intermolecular interactions stabilize the crystal lattice 
between the neighboring quinoline moieties (Figure S7, Table S10). 
The closest copper-copper distance is 6.534(5) Å in this structure. 
[Cu(HQ-4)2(CH3OH)]·ZnCl4·CH3OH crystallized in the triclinic crystal 
system, space group P-1 (Figures 5, S8). The two HL ligands are 
coordinated via the (N,O
-
) donor set resulting in a square planar 
geometry. The fifth (axial) coordination position is occupied by a 
methanol-OH group with Cu1-O3 distance of 2.314(4) Å. Although 
the copper-copper distance (3.8354(8) Å) is significantly larger than 
in crystal [Cu(Q-3)2]·Cl2 the arrangement of the pair of complexes is 
very similar to it, the complexes are placed face to face with their 
parallel basal planes such as O2 is arranged in the axial position of a 
neighboring copper ion (and vice versa, see Figure S8). Intra- and 
intermolecular interactions can be found in Table S11. 
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Correlations between solution equilibrium constants and in vitro 
cytotoxicity 
While the low number of the compounds did not allow statistically 
valid conclusions, we attempted to correlate the solution 
equilibrium properties of the studied 8-hydroxyquinolines with 
their biological activity. Correlation between the in vitro cytotoxicity 
(IC50) obtained in the MES-SA/Dx5 cancer cell line, lipophilic 
character (logD7.4), proton dissociation constants (pKa) of the 
compounds and their metal binding abilities (pM values) were 
analyzed (Figure 6). No relationship was found between the IC50 and 
logD7.4 values (Table 1, Scheme 2) suggesting that lipophilicity as a 
single parameter is not a predictor of cytotoxicity of the studied 
ligands, despite the often well-established correlations between 
biological activity and lipophilicity of cytotoxic drug molecules, as 
the latter strongly affects membrane permeability. Whereas there 
was no strong correlation between pIC50 and pKa (NquinolinidiumH
+
) 
values, cytotoxicity seemed to increase with lower pKa values of the 
hydroxyl moiety (Figure 6.a,b). Furthermore, compounds with 
weaker copper(II) and iron(III) binding abilities (at physiological pH) 
seemed to be more toxic, as suggested by the relation of pM and 
pIC50 values (Figure 6.c,d). The more cytotoxic Q-4 and Q-3 
depending on the metal-to-ligand ratio form positively charged 
complexes at pH 7.4 with both metal ions (Q-4: [CuL2H]
+
, [CuL]
+
 and 
[FeL2H]
2+
;
 
Q-3: [CuL2]
2+
, [CuL]
2+
 and [FeL2]
3+
), while the less active 
compounds (Q-1 and Q-1) mostly form neutral complexes (Q-1: 
[CuL2], [CuL]
+
 and [FeL3];
 
Q-2: [CuL2], [CuL2H]
+
, [CuL]
+
 and [FeL3]). 
 
 
 
Fig. 6. Correlations between pIC50 values measured in MES-SA/Dx5 cell lines 
(IC50: mol/L) and pKa (OH) (a), pKa (NquinolinidiumH
+) (b), pFe(III)* (c) and pCu(II) 
(d) of the studied 8-hydroxyquinolines. Data are taken from Tables 1, 2 and 
Scheme 2. 
 
Redox properties of the studied 8-hydroxyquinolines with iron(III) 
and copper(II) 
In addition to solution stability, the toxicity of metal complexes is 
also influenced by their redox properties. We therefore 
characterized the redox features of the copper(II) and iron(III) 
complexes of the studied 8-hydroxyquinoline ligands. First, the 
redox activity of iron(III) and copper(II) complexes was investigated 
by cyclic voltammetry (CV). The CV measurements were carried out 
in pure DMSO due to the low water solubility of these metal 
complexes (c << 0.5 mM). However, aprotic organic solvents can 
modify complex formation processes and redox properties. Reliable 
data could be collected only for the complexes formed with Q-1 and 
Q-3, when quasi-reversible redox processes were observed. 
Representative voltammograms recorded for the complexes formed 
with Q-3 at different metal-to-ligand ratios are shown in Figure 7 
and for the complexes formed with the other ligands in Figure S9. 
The corresponding electrochemical data are collected in Table S12. 
Based on the voltammograms it could be concluded that upon 
complex formation with Q-1 and Q-3, the half-wave potentials (E1/2) 
are shifted to more negative potentials compared to those of the 
corresponding metal salts. (Ligands Q-3 and Q-2 were found to be 
redox active as well, but their identified cathodic peaks appear at 
much lower potentials than the peaks belonging to the metal 
complexes (Figure S9, Table S12).) On the other hand, redox 
processes of the copper(II/I) systems occur at lower potential 
ranges compared to the iron containing systems. Interestingly, the 
observed shifts from the half-wave potentials of the metal salts 
were much bigger in case of ligand Q-1 as compared to Q-3 for both 
metal ions. Thus, Q-3, the more cytotoxic ligand, stabilizes the 
lower oxidation states of iron and copper more than Q-1. 
 
 
Fig. 7. Cyclic voltammograms of the iron(III) – Q-3 (a) and copper(II) – Q-3 
(b) systems. Ligand alone (black / deprotonated: grey), FeCl3 (brown), iron 
complexes at the M:L ratios 1:1 (bordeaux), 1:2 (red) and 1:3 (orange), as 
well as for CuCl2 (light blue), and copper complexes at the M:L ratios 1:1 
(blue) and 1:2 (green). (Potentials measured against Ag/AgCl/KCl (3 M); cQ-3 
=1.0 mM; solvent: DMSO; I = 0.01 M (TBAClO4); T = 25 °C; scan rate = 
5 mV/s) 
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Fig. 8. Time-dependent UV–Vis spectra of the copper(II) complexes of Q-2 
(a) upon addition of 2.5 equivalents of GSH at pH 7.40. Black dashed lines 
denote the initial spectra before addition of GSH, red dashed lines the 
spectra upon addition of H2O2 (a). Absorbance values measured at 370 nm 
plotted against the time (b). (ccopper(III) = 100 M; cligand = 100 M; cGSH = 
250 M; T = 25.0 ˚C; I = 0.20 M KCl) 
 
 In comparison to the formal potential of -0.26 V reported for the 
redox couple of oxidized glutathione/glutathione (GSSG/GSH) at 
physiological pH,
45
 the determined E1/2 value of the iron-Q-3 complex 
is more positive (Table S12), suggesting that GSH might be able to 
reduce this iron(III) complex, while the reduction of the iron(III) 
complex of Q-1 by GSH seems unlikely based on these data. However, 
since the CV data were obtained in DMSO solutions, care is 
warranted in extrapolating the obtained results to the intracellular 
milieu. Therefore, the direct reactions of the iron(III) and copper(II) 
complexes of Q-1 to Q-4 with two physiologically relevant reducing 
agents GSH and ascorbate (ASC) were followed by UV‒Vis 
spectrophotometry under strictly anaerobic conditions. Absorbance 
spectra were analyzed at  > 310 nm, where neither the reduced 
nor the oxidized forms of GSH and ASC absorb light.
46,47
  
No significant spectral changes were observed upon reaction of the 
iron(III) complexes with 2.5 equivalents of GSH (in HEPES buffer, pH 
7.4) within a time frame of 90 min. It was reported that the 
reduction of some iron(III)
47
 and vanadium(V)
46,48
 complexes by GSH 
might be kinetically hindered, while the dehydro-L-ascorbic 
acid/ASC redox pair (E°’ at physiological pH = +0.05 V),
49
 reacts 
considerably faster. Redox reactions of the iron(III) complexes with 
ASC were observed at pH 6.87 as shown in Figure S10, although the 
spectral changes were still minor under the conditions, especially in 
the case of Q-3 and Q-4. Addition of H2O2 to the samples reverses 
these changes. 
Notably, the copper complexes have lower redox potentials than 
the iron compounds (Table S12), thus the copper(II) complexes are 
less powerful oxidizing agents. Nevertheless, copper(II) complexes 
of Q-1 to Q-4 show characteristic spectral changes upon reaction 
with GSH, as displayed exemplarily for the complex of Q-2 in 
Figure 8. The significant decrease of the absorbance values at the 
max of the copper(II) complex occurred relatively fast, indicating a 
possible ligand release from the reduced copper(I) complex. In 
order to assess whether the observed reduction process of the 
copper(II) complex is reversible, H2O2 was added to the samples at 
the end of the reaction. Upon addition of the oxidizing agent the 
spectrum of the original copper(II) complex reappeared, indicating 
the reversibility of the redox process and the possibility of an 
intracellular redox-cycling reaction. The time course of spectral 
changes induced by the reaction of the various copper(II) 
complexes with GSH are compared in Figure S11. The observed rate 
constants (kobs) of the redox reactions, calculated based on the 
initial slope of the ln(A/A0) vs. t plots (not shown), were as follows: 
0.15
 
min
-1
 for Q-1, 0.21
 
min
-1
 for Q-2, 0.20
 
min
-1
 for Q-3, 0.02
 
min
-1
 
for Q-4. This trend indicates that a stronger copper(II) binding 
ability of ligands is accompanied by the faster redox reaction of 
their complex with GSH. Despite the trend in the kinetics of the 
reduction of the copper complexes, showing the slowest reaction 
for the most toxic ligand, a clear quantitative relationship could not 
be established between the redox chemical characteristics and the 
cytotoxic activity of the compounds. 
Conclusions 
8-Hydroxyquinoline derived Mannich bases were shown to exhibit 
high potency against human cancer cell lines, and the importance of 
a CH2-N building block at position 7 has also been described.
27
 As 
the biological activity of a chelator can be affected by the 
lipophicility, pKa values, metal binding abilities and redox properties 
of the forming complexes, the possible relationship between these 
parameters was monitored in detail in the case of 8-
hydroxyquinoline (Q-1) and its three derivatives containing the 
crucial CH2-N moiety. Due to the protonated tertiary amine 
nitrogens in 7-(morpholinomethyl)quinolin-8-ol (Q-2) and 7-
(piperidin-1-ylmethyl)quinolin-8-ol (Q-3), the hydrophilicity is 
increased as compared to Q-1, while the newly synthesized and 
characterized 5-chloro-7-((2-fluorobenzylamino)methyl)quinolin-8-
ol (Q-4) possesses a more lipophilic character. In addition, the 
various substitutions of the Q-1 scaffold altered the size, the acid-
base character, charges and the metal ion chelation of the 
compounds. To evaluate the effect of these alterations on the in 
vitro anticancer activity of the compounds, cytotoxicity of Q-1 to Q-
4 was tested against the drug resistant human uterine sarcoma 
MES-SA/Dx5 cell line as well as against primary hepatocytes. All 
compounds showed marked cytotoxic activity (IC50 values 0.20-
3.27 M) in the cancer cells increasing in the following order Q-2 < 
Q-1 < Q-3 < Q-4. IC50 values obtained in primary hepatocytes 
revealed the much better selectivity of the studied compounds 
towards cancer cells than the chemotherapy agent doxorubicin. 
Even though the most lipophilic derivative Q-4 was found to be the 
most toxic, no clear relationship was apparent between the 
lipophilicity of the set of derivatives and their toxicity, suggesting 
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that the cytotoxicity of the compound series is not increased with 
membrane permeability. 
Relationship between proton dissociation constants and cytotoxicity 
Based on the determined pKa values, the compounds predominate 
in their neutral forms at physiological pH; although Q-3 and Q-4 are 
mostly present in their zwitterionic L and HL forms, respectively. As 
compared to Q-1, the pKa values of the quinolinium-NH
+
 decrease 
due to the electron withdrawing effect of the various substituents 
in Q-2 to Q-4, and the pKa of the phenolic-OH moiety is reduced in 
Q-3 and Q-4. On the other hand, the morpholino substituent in 7-
position increases the pKa (OH) as a consequence of an 
intramolecular hydrogen bond between the OH and the 
morpholine-N in the HL form of the ligand. Formation of 
intramolecular hydrogen bonding is also feasible in the solid Q-3 
and Q-4·HCl·H2O according to their single crystal X-ray diffraction 
analysis interestingly. It was concluded that compounds with lower 
pKa (OH) values posses lower IC50 values in the MES-SA/Dx5 cancer 
cell lines showing a linear relationship. 
Solution speciation and solid structures of the complexes 
Formation of mono and bis complexes with copper(II) and iron(III) 
was found based on the UV-visible spectrophotometric titrations, 
whereas tris iron(III) complexes could also be detected for most of 
the ligands. At physiological pH, the copper(II) binding strength of 
the studied compounds follow the order Q-2 > Q-1 > Q-3 > Q-4 and 
a similar trend was determined for the iron(III) complexes (Q-1 ~ Q-
2 > Q-3 > Q-4). The studied 8-hydroxyquinolines have a binding 
preference to coper(II) over iron(III) at pH 7.4. Results of the EPR 
spectroscopic measurements and the solid phase structures of 
[(Cu(HQ-2)2)2]·(CH3OH)2·Cl4·(H2O)2, [Cu(Q-3)2]·Cl2 and [Cu(HQ-
4)2(CH3OH)]·ZnCl4·CH3OH characterized by single-crystal X-ray 
diffraction analysis confirmed the coordination via the (N,O) donor 
set in the copper(II) complexes. 
Relationship between solution stability, redox properties and 
cytotoxicity 
In the investigated set of compounds, those possessing weaker 
copper(II) and iron(III) binding abilities at physiological pH were 
found to be more toxic against the cancer cell line. Based on the 
cyclic voltammetric data of the iron and copper complexes, the 
more cytotoxic Q-3 stabilizes the lower oxidation states of these 
metal ions more than Q-1. Glutathione was not able to reduce the 
iron(III) complexes of the tested 8-hydroxyquinolines at five fold 
excess within a time frame of 90 min, while copper(II) complexes 
could be reduced much faster, and in a reversible manner. The 
compounds with stronger copper(II) binding abilities showed faster 
redox reactions and were found to be less cytotoxic. 
In all, the established property-activity relationship for the studied 
compounds can help in understanding the mechanism of action of 
8-hydroxyquinolines and can contribute to the development of 
anticancer compounds. We found that introduction of the 
morpholine moiety at position 7 slightly reduced cytotoxicity of 8-
hydroxyquinoline in MES-SA/Dx5 cell line, at the same time the 
piperidine and fluorobenzylamino substituents (with chlorine at 
position 5) increased the activity. The morpholine derivative has 
higher, while the latter two compounds have much lower pKa (OH) 
than the reference compound Q-1. The more cytotoxic ligands 
possess weaker iron(III) and copper(II) binding abilities than Q-1. 
Based on these conclusions, Q-4 was selected as candidate for 
undergoing preclinical in vivo experiments. 
Experimental Section 
Chemicals 
Solid KOH, 8-hydroxyquinoline (Q-1), 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), tetrabutylammonium 
chloride (TBACl), ferrocene, 5-chloroquinolin-8-ol, 2-
fluorobenzylamine, paraformaldehyde, ascorbic acid (ASC) and 
glutathione (GSH) were purchased from Sigma-Aldrich and HCl, KCl, 
CuCl2, FeCl3, n-octanol were Reanal products (Budapest, Hungary). 
The Q-2 (NSC662298) and Q-3 (NSC57969) were acquired from the 
drug repository of the Developmental Therapeutics Program of the 
National Cancer Institute. Iron(III) and copper(II) stock solutions 
were prepared by dissolving the appropriate amount of the metal 
chlorides in known amounts of HCl. Their concentrations were 
determined by complexometry via the EDTA complexes. Accurate 
strong acid content of the metal stock solutions was determined by 
pH-potentiometric titrations. The studied 8-hydroxyquinolines were 
poorly soluble in water; therefore stock solutions (0.01 M; 1.4-
3.7 g/L) were in pure DMSO. Solubility in water was not determined 
experimentally, but based on the determined logD7.4 values we can 
conclude that Q-2 and Q-3 have somewhat better, while Q-4 has 
definitely a worse (~50 M) water solubility than Q-1 (S ~ 0.56 g/L, 
~4 mM). (The solubility of these compounds strongly depends on 
the pH.) 
Chemicals used for synthesis were of reagent grade quality or 
better, obtained from commercial suppliers and used without 
further purification. Solvents were used as received or dried. 
 
Synthesis and characterization of 5-chloro-7-((2-
fluorobenzylamino)methyl)quinolin-8-ol hydrochloride (Q-4∙HCl) 
Q-4·HCl was obtained by the acidic cleavage of 5-chloro-3-(2-
fluorobenzyl)-3,4-dihydro-2H-[1,3]oxazino[5,6-h]quinoline, which 
was prepared by the reaction of 5-chloroquinolin-8-ol (0.50 g, 2.78 
mmol), 2-fluorobenzylamine (0.52 g, 4.15 mmol) and 
paraformaldehyde (0.208 g, 6.95 mmol) using ethanol (17 mL) as 
solvent in a 35 mL pressurized reaction vial. The mixture was 
heated by microwave irradiation at 100 ºC for 45 min. The solvent 
was then evaporated off and the residue was crystallized with n-
hexane:ethyl acetate (5:1; 30 mL) and recrystallized from 20 mL of 
diisopropyl ether. Yield: 0.795 g (87%); mp.: 150-152 °C. 
1
H NMR 
(DMSO-d6, Figure S12): δ = 3.96 (2H, s); 4.08 (2H, s); 5.11 (2H, s); 
7.12-7.26 (2H, m); 7.36 (1H, t, J = 7.6 Hz); 7.41-7.52 (2H, m); 7.65 
(1H, dd, J = 8.12 Hz, 3.84 Hz); 8.46 (1H, d, J = 8.5 Hz); 8.92 (1H, s); 
13
C NMR (DMSO-d6, Figure S13): δ = 48.3; 48.7; 61.7; 115.2; 115.4; 
118.6; 120.1; 122.5; 124.4; 124.9; 125.0; 126.4; 129.4; 131.1; 132.2; 
139.4; 148.8; 149.9. Anal. calcd. for C18H14ClFN2O (328.77): C, 65.76; 
H, 4.29; N, 8.52. Found: C, 66.02; H, 4.31; N, 8.49. 
To obtain Q-4·HCl 0.15 mL (1.0 mmol) of HCl/ethanol (22%) was 
added to a stirred solution of 5-chloro-3-(2-fluorobenzyl)-3,4-
dihydro-2H-[1,3]oxazino[5,6-h]quinoline (0.20 g; 0.6 mmol) in 
ethanol (15 mL). The mixture was stirred for 30 min at room 
temperature. After evaporation of the solvent and crystallization 
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with diethyl ether (10 mL), the product was obtained in 91% yield 
(0.19 g); mp.: 211-213 °C. 
1
H NMR (DMSO-d6, Figure S14): δ = 4.25 
(2H, s); 4.37 (2H, s); 7.22-7.32 (2H, m); 7.43-7.53 (1H, m); 7.75 (1H, 
t, J = 7.2 Hz); 7.81 (1H, dd, J = 8.24 Hz, 3.97 Hz); 8.00 (1H, s); 8.56 
(1H, d, J = 8.2 Hz); 9.02 (1H, s); 9.85 (2H, brs); 
13
C NMR (DMSO-d6, 
Figure S15): δ = 43.0; 44.1; 114.9; 115.6; 118.4; 119.0; 119.1; 123.8; 
124.6; 126.2; 129.4; 131.5; 132.5; 133.0; 138.4; 149.3; 151.9. Anal. 
calcd. for C17H15Cl2FN2O (353.22): C, 57.81; H, 4.28; N, 7.93. Found: 
C, 57.92; H, 4.27; N, 7.95. 
1
H and 
13
C NMR spectra were recorded in deuterated solvents on 
400 (
1
H: 400 MHz, 
13
C: 100.6 MHz) MHz spectrometer at room 
temperature. Chemical shifts δ are expressed in ppm values using 
the residual solvent peaks as internal standards (DMSO-d6 2.50; 
39.52 ppm).
50
 Melting points were determined on a Hinotek X-4 
type melting point apparatus and are uncorrected. Elemental 
analyses were performed with a Perkin-Elmer 2400 CHNS elemental 
analyzer. Merck Kieselgel 60F254 plates were used for TLC. 
Microwave reactions were performed by using CEM LabMate 
microwave reactor. 
 
Crystallization, X-ray data collection, structure solution and 
refinement 
Single crystals suitable for X-ray crystallography (SXRD) (Q-3, Q-
4·HCl·H2O, [(Cu(HQ-2)2)2]·(CH3OH)2·Cl4·(H2O)2, [Cu(Q-3)2]·Cl2 and 
[Cu(HQ-4)2(CH3OH)]·ZnCl4·CH3OH) were grown from slow 
evaporation of a methanolic solution at room temperature. In case 
of the crystallisation of the copper complexes the solution 
contained the metal ion and the ligand at 1:2 ratio. [Cu2(Q-
2)4]·(CH3OH)2·(Cl)4·(H2O)2 and [Cu(Q-3)]·(Cl)2 were crystallized from 
methanolic solutions applying vapour diffusion of diethyl ether to 
reduce the solubility. The complex of Q-4 could not be crystallized 
under similar conditions, however when ZnCl2 was also present in 
the solution the crystals of [Cu(Q-4)]·(ZnCl4)·(CH3OH) could be 
obtained. As Cu and Zn could not be unambiguously distinguished 
by SXRD, elemental analysis (ICP-OES) has been performed. This 
crystal contains 2.6(1) mg/kg of Cu and 4.0(2) mg/kg of Zn that is 
60/40 % Zn/Cu ratio (with an error of ±5%). If we suppose that in 
this crystal the Zn is possibly in a tetrahedral ZnCl4 form (40%) and 
Cu is complexed by the Q-4 ligands (40%), there is still 20% of Zn 
shared, half in ZnCl4 and the other half possibly occupies the 
position of copper in the Q-4 complex. It means an 80% copper(II) 
and 20% zinc(II) occupation of the central metal position of the 
organic ligand complex cation, which may be the reason of the poor 
crystal quality, which prevented the refinement of the metal 
occupancy on the weak quality SXRD data. 
The single crystals were mounted on loops. X-ray diffraction data 
were collected on a Rigaku RAXIS-RAPID II diffractometer at room 
temperature (293 K) in case of Q-3, Q-4·HCl·H2O, [(Cu(HQ-
2)2)2]·(CH3OH)2·Cl4·(H2O)2, [Cu(Q-3)2]·Cl2, while the temperature was 
103 K during the measurement of [Cu(HQ-
4)2(CH3OH)]·ZnCl4·CH3OH). Numerical absorption correction was 
carried out, except the last crystal where multi-scan absorption 
correction has been applied by the software CrystalClear.
51
  
Sir2014
52
 and SHELXL
53
 under WinGX
54
 software were used for 
crystal structure solution and refinement, respectively. The 
structures were solved by direct methods. The models were refined 
by full-matrix least squares on F
2
. Hydrogen atoms were included in 
structure factor calculations but they were not refined, their 
isotropic displacement parameters were approximated from the 
U(eq) value of the atom they were bonded to. Refinement of non-
hydrogen atoms was carried out with anisotropic temperature 
factors. Selected bond lengths and angles of compounds were 
calculated by PLATON software.
55
 The graphical representations 
were done by Mercury
56
, and the edition of CIF files were 
performed by PublCif 
57
 software, respectively. 
Crystallographic data for the crystal structures were deposited at 
the Cambridge Crystallographic Data Centre as supplementary 
publication number CCDC 1575107-1575111 for the five crystals 
listed above. 
 
UV‒Vis spectrophotometry and determination of the distribution 
coefficients 
The pH-metric measurements for determination of the exact 
concentrations of HCl and KOH stock solutions used for the 
spectrophotometric titrations were carried out at 25.0 ± 0.1 
o
C in 
aqueous solutions and at an ionic strength of 0.20 M KCl in order to 
keep the activity coefficients constant. All the titrations were 
performed with carbonate-free KOH solutions of known 
concentration (0.10 M) in the presence of 0.1 M KCl. An Orion 710A 
pH-meter equipped with a Metrohm combined electrode (type 
6.0234.100) and a Metrohm 665 Dosimat burette were used for 
titrations. The electrode system was calibrated to the pH = ‒log[H
+
] 
scale by the method suggested by Irving et al.
58
 The average water 
ionization constant, pKwater, is 13.76 ± 0.01 at 25 
o
C. Samples were 
deoxygenated by bubbling purified argon for ca. 10 min prior to the 
measurements and argon was also passed over the solutions during 
further titrations. A Hewlett Packard 8452A diode array 
spectrophotometer was used to record the UV‒Vis spectra in the 
200 - 800 nm interval. The path length was 1 or 2 cm. The 
spectrophotometric titrations were performed on samples of 
ligands Q-3, Q-4 and Q-2 alone or with iron(III) or copper(II). The 
concentration of the ligand was usually 50 µM (10 µM for Q-4 due 
to its worse water solubility) and the metal ion-to-ligand ratios 
were 1:1, 1:2 and 1:3 over the pH range between 2 and 11.5 at an 
ionic strength of 0.20 M (KCl) at 25.0 ± 0.1 
o
C. The initial volume of 
the samples was 10.00 mL. The samples contained 0.5% (v/v) 
DMSO. Overall protonation constants of ligands (from which the pKa 
values were calculated), the overall stability constants of its metal 
complexes and the individual spectra of the species were computed 
by the program PSEQUAD
59
 and literature data were used for 
iron(III) hydroxido species.
60
 
 (MpLqHr) is defined for the general equilibrium pM + qL + rH 
MpLqHr as  (MpLqHr) = [MpLqHr]/[M]
p
[L]
q
[H]
r 
where M denotes the 
metal ion and L the completely deprotonated ligand. 
The n-octanol/water distribution coefficients (logD7.4) of ligands Q-
3, Q-4 and Q-2 were determined by the shake-flask method in n-
octanol/water solutions at 25.0 ± 0.2 
o
C at pH 7.40 as described 
previously.
16
 
 
EPR measurements 
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The EPR spectra were recorded at room temperature and at 77 K (in 
a dewar containing liquid nitrogen) using a BRUKER EleXsys E500 
spectrometer (microwave frequency 9.81 GHz, microwave power 
13 mW, modulation amplitude 5 G, modulation frequency 100 kHz). 
All EPR spectra were simulated by a spectral decomposition method 
using “EPR” program.
61
 Since the copper(II) salt used to make the 
stock solution was a natural mixture of isotopes, the spectrum of 
each species was calculated as the sum of spectra containing 
63
Cu 
and 
65
Cu weighted by their natural abundances. The copper and 
ligand coupling constants are given in units of gauss (1 G = 10
–4
 T). 
The EPR spectra of the dimeric complex was simulated by a new 
modul of the ’EPR’ program
61
 developed for calculating EPR spectra 
and dynamic nuclear polarization (DNP) in coupled spin systems 
(biradicals and paramagnetic dimers). The EPR spectrum is 
calculated by the complete diagonalization of the Hamiltonian of a 
two-spin system. The details of the simulation was published 
previously.
62 
 
Cyclic voltammetric measurements 
All cyclic voltammograms of the iron(III) and copper(II) complexes 
were measured in DMSO (with a H2O content of up to 1.6% for 
copper samples and 3.7% for iron samples) at 25.0 ± 0.1 °C and at 
an ionic strength of 10 mM (TBAClO4). Samples contained 1.0 mM 
metal ion or 1.0 mM ligand (Q-1, Q-2, Q-3, Q-4) alone or together 
while the cL/cM ratios were 1, 1.5, 2 or 3. Measurements were 
performed on a conventional three-electrode system under argon 
atmosphere and a PC controlled Autolab-PGSTAT 204 potentiostat. 
Samples were purged for 15 min with argon before recording the 
cyclic voltammograms. A glassy carbon electrode was used the 
working electrode, a platinum electrode as the auxiliary electrode 
and a Ag/AgCl/KCl (3 M) as reference electrode. Electrochemical 
potentials were converted into the normal hydrogen electrode 
(NHE) scale by adding 0.210 V.
63
 The electrochemical measuring 
system was calibrated with ferrocene in 95 % (v/v) DMSO-water 
(E1/2 = +0.50 ± 0.03 V vs. Ag/AgCl/KCl (3 M) in our setup).
 
Redox 
potentials were obtained at 5 mV/s scan rate in the range of –1.2 to 
+1.0 V. 
 
Reduction by GSH and ASC 
Reduction of the copper(II) and iron(III) complexes of ligands Q-1 to 
Q-4 by GSH and ASC, respectively, was studied by UV‒Vis 
spectrophotometry using a Hewlett Packard 8452A diode array 
spectrophotometer. A special, tightly closed tandem cuvette 
(Hellma Tandem Cell, 238-QS, path length: 1 cm) was used and the 
reactants were separated until the reaction was triggered. Both 
isolated pockets of the cuvette were completely deoxygenated by 
bubbling a stream of argon for 10 min before mixing the reactants. 
Spectra were recorded before and immediately after mixing, and 
changes were followed during 90 min. One of the isolated pockets 
contained the reducing agent at five times (GSH) and 2.5 times 
(ASC) higher concentrations than that of the metal ions. The other 
pocket contained the metal ions (Cu(II); Fe(III): 100 µM) and ligands 
at 1:1 metal-to-ligand ratio. The pH of the solutions was adjusted to 
7.40 by 50 mM HEPES buffer, or to 6.87 by a mixed acetate:PBS 
buffer (ratio 1:4), and an ionic strength of 0.1 M (KCl) was applied at 
25.0 ± 0.1 °C. At the end of the measurements cc. H2O2 (50 µL to 1.4 
mL sample) was added to the samples. 
 
Cell lines and culture conditions 
The doxorubicin selected human uterine sarcoma MES-SA-Dx5 cell 
line was obtained from ATCC (MES-SA/Dx5: No. CRL-1977™). Cells 
were cultivated in Dulbecco’s Modified Eagle Medium (DMEM, 
Sigma Aldrich, Hungary), supplemented with 10% fetal bovine 
serum, 5 mM glutamine, and 50 unit/mL penicillin and streptomycin 
(Life Technologies). All cell lines were cultivated at 37 °C, 5% CO2. 
For the preparation of the primary mouse hepatocytes mouse 
handling and experimental procedures were conducted in 
accordance with institutional guidelines for animal care and use. 16 
weeks old male C57BL/6 mice were anaesthetized (20 mg/kg 
tiletamine, 20 mg/kg zolazepam, 12.5 mg/kg xylazine and 3 mg/kg 
butorphanol) and livers were perfused with 75 mL oxygenized 
perfusion buffer (120 mmol/L NaCl, 5.4 mmol/L KCl, 0.9 mmol/L 
NaH2PO4, 26 mmol/L NaHCO3, 5.6 mmol/L glucose, pH 7.4) 
supplemented with EGTA (0.5 mmol/L), followed by a second 
perfusion with 75 mL perfusion buffer without EGTA. Collagenase 
digestion was performed by 75 mL perfusion buffer supplemented 
with 2.5 mmol/L CaCl2 and 0.2 mg/mL collagenase (C5138, Sigma). 
The digested liver was taken out of the abdominal cavity and 
minced using tweezers, thereby releasing the hepatocytes. Cells 
were washed in ice-cold sterile suspension buffer (10 mmol/L 
HEPES, 142 mmol/L NaCl, 7 mmol/L KCl, pH 7.4), filtered through a 
100 µm mesh membrane and centrifuged for 4 min at 4 ˚C at 80 g. 
After one additional washing step, dead cells were removed by 
Percoll (Sigma) centrifugation. After checking their viability by 
Trypan Blue exclusion staining, cells were seeded on 96-well plates 
pre-coated with 5 µg/cm
2
 Collagen I (BD, 356234) at a density of 
1.35×10
4 
cells/well in Williams E medium (Gibco) supplemented 
with hepatocyte thawing/plating supplement (Gibco) and 10% FBS. 
Cells that did not attach were removed by refreshing the culture 
medium after 1 h. Medium was renewed every 24 h during the 
culture as well as during the experiment (containing the dilutions of 
tested compounds). 
 
MTT and Presto Blue viability assay 
MTT viability assays were performed as described earlier with 
minor modifications.
47,64,65
 Briefly, cells were seeded into 96-well 
tissue culture plates (Sarstedt, Newton, USA / Orange, Braine-
l'Alleud, Belgium) a density of 5000 cells/well and allowed to attach 
overnight. Test compounds were added to achieve the required 
final concentration in a final volume of 100 µL per well. After an 
incubation period of 72 h, the supernatant was removed and fresh 
medium supplemented with the MTT reagent (0.083 mg/mL) was 
added. Incubation with MTT at 37 °C was terminated after 1 h by 
removing the supernatants and lysing the cells with 100 µL DMSO 
per well. Viability of the cells was measured spectrophotometrically 
by absorbance at 540 nm using either a Perkin Elmer Victor X3 or 
EnSpire microplate reader, respectively. Data were background 
corrected by subtraction of the signal obtained from unstained cell 
lysates and normalized to untreated cells. 
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On primary mouse hepatocytes, Q-1 to Q-4 were measured by 
PrestoBlue assay (Life Technologies) as described earlier.
27
  Briefly, 
after the incubation with the compounds for 72 h and removal of 
supernatants, a diluted solution of the PrestoBlue reagent (10%) 
was added to each well. After incubation with the reagent for one 
hour at 37 °C emission was measured at 579 nm upon excitation at 
540 nm using a Perkin Elmer EnSpire microplate reader.  
Curves were fitted by Prism software
66
 using the sigmoidal dose-
response model (comparing variable and fixed slopes). Curve fit 
statistics were used to determine the concentration of test 
compound that resulted in 50% toxicity (IC50). 
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